Cardiff Oncology Inc. buy secretariat
Start price
19.09.20
/
50%
€7.40
Target price
23.09.20
-
Performance (%)
34.46%
End price
23.09.20
€9.95
Summary
This prediction ended on 23.09.20 with a price of €9.95. With a performance of 34.46% the BUY prediction by secretariat was a big success. secretariat has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cardiff Oncology Inc. | -5.849% | -5.849% | -24.508% | 76.575% |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% | 64.626% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% | 109.421% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% | 57.591% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% | 68.003% |
According to secretariat what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by secretariat for this prediction
In the thread Trovagene diskutieren
Buy Cardiff Oncology Inc.